Meridian Bioscience/ US5895841014 /
30/01/2023 21:59:52 | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
33.98USD | - | 112,605 Turnover: 3.83 mill. |
-Bid Size: - | -Ask Size: - | 1.5 bill.USD | - | 35.02 |
Assets
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 26.1000 | 27.6100 | 27.4920 | 30.4500 | 30.5100 | ||||||
Intangible Assets | 8.1000 | 7.8130 | 5.9310 | 29.8550 | 26.7040 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | 64.1810 | 60.4290 | 125.0320 | 115.9020 | ||||||
Inventories | 34.8000 | 35.4950 | 35.8170 | 45.0570 | 41.4930 | ||||||
Accounts Receivable | 26.2000 | 23.2320 | 26.2540 | 27.1020 | 29.1060 | ||||||
Cash and Cash Equivalents | 44.3000 | 43.0470 | 49.9730 | 47.2260 | 57.0720 | ||||||
Current Assets | 114.1000 | 112.7480 | 122.8530 | 126.7910 | 133.8750 | ||||||
Total Assets | 176.7000 | 176.9290 | 183.2820 | 251.8230 | 249.7770 |
Liabilities
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 5.6000 | 4.9660 | 6.6460 | 7.6270 | 7.7190 | ||||||
Long-term debt | - | 0.0000 | 0.0000 | 54.6100 | 50.1470 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | 2.8000 | 4.5000 | ||||||
Liabilities | 21.7000 | 15.9000 | 17.4090 | 85.3510 | 80.1920 | ||||||
Share Capital | - | - | - | - | - | ||||||
Total Equity | 155 | 161.0290 | 165.8730 | 166.4720 | 169.5850 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 176.7000 | 176.9290 | 183.2820 | 251.8230 | 249.7770 |
Income Statement
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 188.7000 | 188.8320 | 194.8300 | 196.0820 | 200.7710 | ||||||
Depreciation (total) | - | 5.5620 | 5.2180 | 6.6270 | 8.1180 | ||||||
Operating Result | 57.3000 | 52.3920 | 56.0600 | 51.3780 | 37.3820 | ||||||
Interest Income | .0400 | .0250 | .0230 | -.8300 | -1.4710 | ||||||
Income Before Taxes | 57.4000 | 52.1080 | 55.0630 | 50.6440 | 36.4290 | ||||||
Income Taxes | 19.3000 | 17.3650 | 19.5230 | 18.4150 | 14.8720 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 38 | 34.7430 | 35.5400 | 32.2290 | 21.5570 |
Per Share
Cash Flow
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 44.4000 | 38.2620 | 42.8090 | 37.2230 | 41.3550 | ||||||
Cash Flow from Investing Activities | -3.3000 | -7.0020 | -3.6260 | -66.6950 | -4.4670 | ||||||
Cash Flow from Financing | -28.6000 | -31.7530 | -30.7430 | 27.2050 | -27.7130 | ||||||
Decrease / Increase in Cash | 12.7000 | -1.2350 | 6.9260 | -2.7470 | 9.8460 | ||||||
Employees | - | - | 580 | 650 | 420 |